Delivery Order SPE2DB22D3301-SPE2DB24FY8MB
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $3,643.75 Firm Fixed Price delivery order is for the supply of VEMLIDY 25 MG TABLET in a 30-count package. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,905.19 firm-fixed-price delivery order is for VEMLIDY 25 MG TABLET UU 30S, a medical supply. The contract has an ultimate completion date of January 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $5,716.99 firm fixed-price delivery order contract has a period of performance through February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,357.98 firm fixed-price delivery order contract is for the supply of VEMLIDY 25 MG TABLET, a specific pharmaceutical product. The contract has an ultimate completion date of January 23, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $19,174.77 firm fixed price delivery order is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025 and was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $14,923.08, is for the delivery of the prescription medication VEMLIDY 25 MG TABLET UU 30S. This award is not associated with any set-aside designations. Amerisourcebergen holds a single-award IDC with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,113.25 Firm Fixed Price delivery order contract is for the supply of VEMLIDY 25 MG TABLET. The contract has an ultimate completion date of August 17, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,711.97 firm-fixed-price delivery order is for the provision of VEMLIDY 25 MG TABLET product. The award has an ultimate completion date of January 4, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of VEMLIDY 25 MG TABLET in quantities of 30 tablets. The $6,441.91 Firm Fixed Price contract has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The award has a ceiling value of $18,004.18 and an ultimate completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) valued up to...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY8MBDelivery Order
This federal contract award, valued at $5,756.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order contract is for the supply of VEMLIDY 25 MG TABLET, a pharmaceutical product, with a completion date of June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 6/12/24 |